Vascular involvement in systemic sclerosis (scleroderma)
Debendra Pattanaik1, Monica Brown2, Arnold E Postlethwaite11Division of Connective Tissue Diseases, Department of Medicine; 2Section of Pediatric Rheumatology Department of Pediatrics, University of Tennessee Health Science Center, and Department of Veterans Affairs Medical Center, Memphis, TN, USAA...
Enregistré dans:
Auteurs principaux: | Pattanaik D, Brown M, Postlethwaite AE |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7f2ad46947d94c52a6cd3a2d21f4600c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Alemtuzumab in the treatment of multiple sclerosis
par: Fernandez Ó
Publié: (2014) -
Emerging therapies for treatment of multiple sclerosis
par: John R Corboy, et autres
Publié: (2010) -
The effect of smoking on the symptoms and progression of multiple sclerosis: a review
par: Afsaneh Shirani, et autres
Publié: (2010) -
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
par: Slobodan M Jankovic
Publié: (2010) -
Expression analysis of protein inhibitor of activated STAT (PIAS) genes in IFNβ-treated multiple sclerosis patients [Corrigendum]
par: Taheri M, et autres
Publié: (2019)